Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-20 · accession 0001193125-25-293772 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-24 | 2025-11-20 | DLB | Couling John D | SVP, Entertainment | S - Sale | $66.12 | -6,164 | 115.3K | -5% | -$407.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-11-20 | S | D | 6,164 | $66.12 | 115,338 | D | — | — | (F2) Shares include 284 shares and 67 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025 and November 17, 2025, respectively. (F1) Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |